PENS T6 With Ambulatory Self-applied Patch vs Conventional Procedure
NCT02564627 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 90
Last updated 2015-10-01
Summary
A prospective randomized study, including moderately obese patients will be included. Patients will be randomized in 3 groups:
* PENS of dermatome T6 with an ambulatory self-applied patch + 1200Kcal/day diet
* PENS of dermatome T6 with conventional procedure + 1200Kcal/day diet
* Only 1200Kcal/day diet
The effect on appetite and weight loss will be investigated.
Conditions
Interventions
- PROCEDURE
-
Self-applied patch
An ambulatory self-applied patch will be placed weekly by the patients for PENS of dermatome T6.
- PROCEDURE
-
Conventional procedure
PENS of dermatome T6 will be applied by the MD in the Outpatient Clinic.
- DIETARY_SUPPLEMENT
-
1200 Kcal/day diet
A 1200 Kcal/day diet will be prescribed.
Sponsors & Collaborators
-
Abdel Kadar Clinic
lead OTHER
Principal Investigators
-
Mohammed Abdel Kadar · Kadar Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-07-31
- Primary Completion
- 2015-09-30
- Completion
- 2015-09-30
More Related Trials
-
Safety & Effectiveness of TENS Weight Management Compared to a Sham
NCT05675384 ·Status: COMPLETED ·Phase: NA
-
A Study on Efficacy and Safety of Topiramate in Maintaining Weight Loss in Obese Patients Following an Intensive, Non-Pharmacologic Weight Loss Program
NCT00236600 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity
NCT05933499 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus
NCT06616961 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Tirzepatide for Partial Lipodystrophy Treatment: A New Horizon in 2024
NCT07091734 ·Status: RECRUITING ·Phase: PHASE2
-
A Study of the Safety and Effectiveness of JNJ-16269110 (R256918) in Overweight and Obese Patients
NCT00622765 ·Status: COMPLETED ·Phase: PHASE2
-
First in Human Study in Subjects With Obesity, But Otherwise Healthy
NCT06252220 ·Status: RECRUITING ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of (PEG)-BHD1028
NCT06563115 ·Status: COMPLETED ·Phase: PHASE1
-
Zonisamide for Weight Reduction in Obese Adults
NCT00275834 ·Status: COMPLETED ·Phase: NA
-
ELIRA 2: Safety and Effectiveness of TENS Assisted Weight Loss and Appetite Suppression
NCT03936699 ·Status: COMPLETED ·Phase: NA
-
A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using Tirzepatide
NCT04081337 ·Status: COMPLETED ·Phase: PHASE1
-
A Multicenter, Double-blind, Randomized, Parallel-group, Pilot Study of 12-week Duration to Assess the Short-term Safety and Tolerability of Lorcaserin Plus Two Doses of Immediate-Release Phentermine-HCl Compared With Lorcaserin Alone in Overweight and Obese Adults
NCT01987427 ·Status: COMPLETED ·Phase: PHASE4
-
A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity
NCT01180465 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Investigate the Efficacy and Safety of Two Different Doses of Twice Daily Distal Jejunal-release Dextrose Beads Formulations Combined With a Gel Composition Compared to Placebos in Obese Subjects With Weight Related Comorbidities
NCT07008456 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
NCT06500429 ·Status: COMPLETED ·Phase: PHASE2
-
Combination of Topiramate and Empagliflozin is Considered a Good Option for the Treatment of Obesity
NCT04043702 ·Status: COMPLETED
-
Endoscopic Ultrasound Guided Gastric Botulinum Toxin Injections Versus Glucagon Like Peptide 1 Receptor Agonist in Weight Loss
NCT05268627 ·Status: UNKNOWN ·Phase: NA
-
Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects
NCT03041792 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness and Safety of Tirzepatide Among Participants With Obesity With or Without Type 2 Diabetes Mellitus (T2DM)
NCT07099742 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method
NCT01853397 ·Status: COMPLETED ·Phase: NA
-
GLP-1s to Enhance Lasting Optimal Weight
NCT06861439 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
A Study to Determine the Effects of TM30339 on Weight Loss in Obese Individuals.
NCT00746824 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Co-administration of Canagliflozin 300 mg and Phentermine 15 mg With Placebo in the Treatment of Non-Diabetic Overweight and Obese Participants
NCT02243202 ·Status: COMPLETED ·Phase: PHASE2
-
Therapeutic Effects and Effects on Body Fat of GLP-1 Receptor Agonists in Patients With Type 2 Diabetes for 1-4 Years
NCT05990374 ·Status: UNKNOWN ·Phase: NA
-
An Evaluation of the Safety and Efficacy of LIPO-102 for the Reduction of Subcutaneous Abdominal Adiposity
NCT01096979 ·Status: COMPLETED ·Phase: PHASE2